Get all the latest information from the CURE Educated Patient® Prostate Cancer Summit report!
June 17th 2022, 1:00pm
Watch Dr. Jeremie Calais, Dr. Tian Zhang, Dr. Landon C. Brown and Jim Rosenfield answer questions about novel agents and strategies during the CURE Educated Patient Prostate Cancer Summit.
June 16th 2022, 1:00pm
Watch Dr. Landon C. Brown, from Atrium Health Levine Cancer Institute, discuss approaches to hormone therapy, during the CURE Educated Patient Prostate Cancer Summit.
June 15th 2022, 1:00pm
Watch Dr. Tian Zhang, from UT Southwestern Medical Center, discuss novel agents, during the CURE Educated Patient Prostate Cancer Summit.
June 14th 2022, 1:00pm
Watch Dr. Jeremie Calais, from UCLA, discuss novel imaging strategies, during the CURE Educated Patient Prostate Cancer Summit.
June 13th 2022, 1:00pm
Watch Dr. Veda N. Giri, Dr. Umang Swami and Sue Friedman answer questions about genetics and genomics during the CURE Educated Patient Prostate Cancer Summit.
June 12th 2022, 2:00pm
Watch Dr. Umang Swami, from Huntsman Cancer Institute, discuss genomic changes and PARP inhibitors, during the CURE Educated Patient Prostate Cancer Summit.
June 11th 2022, 2:00pm
Watch Dr. Veda N. Giri, from Sidney Kimmel Cancer Center at Thomas Jefferson University, discuss genetic testing and who should get it, during the CURE Educated Patient Prostate Cancer Summit.
June 10th 2022, 1:00pm
Watch Dr. Ganesh Raj, Dr. Andrew Z. Wang, and Bruce Williams, discuss treatment for localized disease, during the CURE Educated Patient Prostate Cancer Summit.
June 9th 2022, 1:00pm
Watch Dr. Andrew Z. Wang, from UT Southwestern Medical Center, discuss approaches to radiation for local disease, during the CURE Educated Patient Prostate Cancer Summit.
June 8th 2022, 1:00pm
Watch Dr. Ganesh V. Raj, from UT Southwestern Medical Center, discuss surgery for localized disease, during the CURE Educated Patient Prostate Cancer Summit.
The Days of a Breast Cancer Survivor
Prostate Cancer Survivor Encourages Men to Speak Up and Get Tested
Ligufalimab Gains FDA Orphan Drug Status for Acute Myeloid Leukemia
Expert Highlights Importance of Understanding Myelofibrosis Treatments